http://www.cnr.it/ontology/cnr/individuo/prodotto/ID199731

AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. (Articolo in rivista)

Type

Label

AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. (Articolo in rivista) (literal)

Anno

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#doi

Alternative label

Grimaldi C, Chiarini F, Tabellini G, Ricci F, Tazzari PL, Battistelli M, Falcieri E, Bortul R, Melchionda F, Iacobucci I, Pagliaro P, Martinelli G, Pession A, Barata JT, McCubrey JA, Martelli AM. (2012)
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications.
in Leukemia
(literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori

Grimaldi C, Chiarini F, Tabellini G, Ricci F, Tazzari PL, Battistelli M, Falcieri E, Bortul R, Melchionda F, Iacobucci I, Pagliaro P, Martinelli G, Pession A, Barata JT, McCubrey JA, Martelli AM. (literal)

Pagina inizio

Pagina fine

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume

Rivista

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroFascicolo

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni

Department of Human Anatomy, University of Bologna, Bologna, Italy; Department of Biomedical Sciences and Biotechnology, University of Brescia, Brescia, Italy; Immunohematology and Transfusion Center, Policlinico S.Orsola-Malpighi, Bologna, Italy; Department of Earth, Life and Environmental Sciences, University of Urbino 'Carlo Bo', Urbino, Italy; Molecular Genetics Institute-National Research Council, IOR, Bologna, Italy; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy; Paediatric Oncology and Hematology Unit Lalla Seràgnoli, University of Bologna, Bologna, Italy; Department of Hematology/Oncology 'L. e A. Seràgnoli', University of Bologna, Bologna, Italy; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal; Department of Microbiology & Immunology, School of Medicine, East Carolina University, Greenville, NC, USA (literal)

Titolo

AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. (literal)

Abstract

The mammalian target of rapamycin (mTOR) serine/threonine kinase is the catalytic subunit of two multi-protein complexes, referred to as mTORC1 and mTORC2. Signaling downstream of mTORC1 has a critical role in leukemic cell biology by controlling mRNA translation of genes involved in both cell survival and proliferation. mTORC1 activity can be downmodulated by upregulating the liver kinase B1/AMP-activated protein kinase (LKB1/AMPK) pathway. Here, we have explored the therapeutic potential of the anti-diabetic drug, metformin (an LKB1/AMPK activator), against both T-cell acute lymphoblastic leukemia (T-ALL) cell lines and primary samples from T-ALL patients displaying mTORC1 activation. Metformin affected T-ALL cell viability by inducing autophagy and apoptosis. However, it was much less toxic against proliferating CD4(+) T-lymphocytes from healthy donors. Western blot analysis demonstrated dephosphorylation of mTORC1 downstream targets. Unlike rapamycin, we found a marked inhibition of mRNA translation in T-ALL cells treated with metformin. Remarkably, metformin targeted the side population of T-ALL cell lines as well as a putative leukemia-initiating cell subpopulation (CD34(+)/CD7(-)/CD4(-)) in patient samples. In conclusion, metformin displayed a remarkable anti-leukemic activity, which emphasizes future development of LKB1/AMPK activators as clinical candidates for therapy in T-ALL. (literal)

Prodotto di

Autore CNR

Prodotto

Autore CNR di

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi

data.CNR.it